Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
NEJM Evidence|February 6, 2024
Intraperitoneal Therapy for Ovarian Cancer - Some Answers, More Questions, and Missed OpportunitiesOladapo O YekuBiochemical Society Transactions|April 13, 2016
Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacyOladapo O Yeku, Renier J BrentjensScientific Reports|September 7, 2017
Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironmentOladapo O Yeku, Terence J Purdon, Mythili Koneru, et al.International Journal of Molecular Sciences|January 28, 2026
Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer TherapyAdam P Jones, Yanxia Zhao, Bo R Rueda, et al.Nature Reviews. Clinical Oncology|June 17, 2026
Antibody-drug conjugates in gynaecological cancers: opportunities and challengesKathleen N Moore, Oladapo O Yeku, Brooke E Howitt, et al.Frontiers in Pharmacology|December 22, 2025
CCR2 improves tumor directed CAR-T cell trafficking in ovarian cancerRaj Kumar, Irva E Veillard, Mengyao Xu, et al.Transactions of the American Clinical and Climatological Association|July 23, 2013
Covert operations: cancer's many subversive tactics in overcoming host defensesDan L LongoBMC Hematology|February 7, 2014
An interview with Dan L. Longo, Section Editor of the Malignant hematological diseases sectionDan L LongoReproductive Sciences (Thousand Oaks, Calif.)|April 24, 2024
High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment OptionsYusuke Matoba, Kyle M Devins, Lara Milane, et al.Perspectives in Biology and Medicine|September 12, 2022
Darwinian Repurposing of Molecular Motifs in an Evolving Redox Environment and Its Biomedical ImplicationsJoseph Loscalzo, Dan L LongoPageof 17